Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care Program Within an Integrated Health-System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster describes the impact of implementing ambulatory clinical pharmacist (ACP)-led medication management services specializing in diabetes care within an integrated HSSP.
Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measureshttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights how the implementation of clinical outcome dashboards helps improve quality of care, patient satisfaction, and overall organizational performance and capabilities in health system specialty pharmacies.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Modelhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
RA Outcomes 2022https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-RA.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS Outcomes 2022https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-MS-Outcomes.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body
Hep-C Outcomes 2022https://shieldshealthsolutions.com/content/uploads/2023/10/web-resources-icon-HepC.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Modelhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights that among patients evaluated at UMass Memorial HIV Clinic, those filling ARV medications at the HSSP exhibited higher rates of viral suppression in comparison to patients utilizing…
Pharmacy Liaison-Managed Diabetes Care Model Yields Positive Outcomeshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This article was originally published by Specialty Pharmacy Continuum GRAPEVINE, Texas—Integrating pharmacy technicians into endocrinology clinics to help manage administrative burdens such as prior authorizations and medication refills for patients…
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomeshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Shields demonstrates its unwavering commitment to specialty patient care through our latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).